While this review highlights ZDHHC5's involvement in neurodegenerative diseases, cancer, and cardiovascular disorders, it is true that direct evidence linking ZDHHC5 modulation to therapeutic outcomes is still limited. The gene discussed is ZDHHC5; the disease is cardiovascular disorder.